Nocebo phenomena in medicine: Their relevance in everyday clinical practice;Nocebophänomene in der Medizin: Bedeutung im klinischen Alltag

Deutsches Arzteblatt International

Volumn 109, Issue 26, 2012, Pages 459-465

  Häuser, Winfried ^a   Hansen, Ernil ^b   Enck, Paul ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CLINICAL PRACTICE; EXPECTATION; HUMAN; MEDICAL STAFF; MEDICINE; NOCEBO EFFECT; REVIEW; VERBAL COMMUNICATION;

EID: 84899770350     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2012.0459     Document Type: Review

References (55)

1. Hróbjartsson A, Gøtzsche PC: Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010; (1): CD003974.
2. Wissenschaftlicher Beirat der Bundesärztekammer: Stellungnahme des Wissenschaftlichen Beirats der Bundesärztekammer "Placebo in der Medizin". www.bundesaerztekammer.de/downloads/StellPlacebo 2010.pdf, Last accessed on 09 November 2011.
3. Kennedy WP: The nocebo reaction. Med World 1961; 95: 203-5.
4. Colloca L, Sigaudo M, Benedetti F: The role of learning in nocebo and placebo effects. Pain 2008; 136: 211-8.
5. Colloca L, Miller FG: The nocebo effect and its relevance for clinical practice. Psychosom Med 2011; 73: 598-603.
6. Enck P, Benedetti F, Schedlowski M: New insights into the placebo and nocebo responses. Neuron 2008; 59: 195-206.
7. Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S, Enck P: Gender and the nocebo response following conditioning and expectancy. J Psychosom Res 2009; 66: 323-8.
8. Benedetti F, Lanotte M, Lopiano L, Colloca L: When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007; 147: 260-71.
9. Colloca L, Benedetti F: Placebo analgesia induced by social observational learning. Pain 2009; 144: 28-34.
10. Pfingsten M, Leibing E, Harter W, et al.: Fear-avoidance behavior and anticipation of pain in patients with chronic low back pain: a randomized controlled study. Pain Med 2001; 2: 259-66.
11. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK: Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008; 65: 220-31.
12. Benedetti F, Amanzio M, Vighetti S, Asteggiano G: The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006; 26: 12014-22.
13. Mitsikostas DD: Nocebo in headaches: implications for clinical practice and trial design. Curr Neurol Neurosci Rep 2012; 12: 132-7.
14. Hansen E, Bejenke C: Negative und positive Suggestionen in der Anästhesie - Ein Beitrag zu einer verbesserten Kommunikation mit ängstlichen Patienten bei Operationen. Anaesthesist 2010; 59: 199-209.
15. Bejenke CJ: Suggestive communication: its wide applicability in somatic medicine. In: Varga K (ed.). Beyond the words: communication and suggestion in medical practice. New York: Nova Science Publishers 2011; 83-96.
16. Cheek D: Importance of recognizing that surgical patients behave as though hypnotized. Am J ClinHypnosis 1962; 4: 227-31.
17. Lang EV, Benotsch EG, Fick LJ, et al.: Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial. Lancet 2000; 355: 1486-90.
18. Varelmann D, Pancaro C, Cappiello EC, Camann WR: Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg 2010; 110: 868-70.
19. Ernst E, Resch KL: Concept of true and perceived placebo effects. BMJ 1995; 311: 551-3.
20. Amanzio M, Corazzini LL, Vase L: A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 2009; 146: 261-9.
21. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, et al.: Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf 2009; 32: 1041-56.
22. Häuser W, Bartram C, Bartram-Wunn E, Tölle T: Systematic review: Adverse events attributable to nocebo in randomised controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy. Clin J Pain 2012; 28: 437-51.
23. Vernia P, Di Camillo M, Foglietta T: Diagnosis of lactose intolerance and the "nocebo" effect: the role of negative expectations. Dig Liver Dis 2010; 42: 616-9.
24. Weissenfeld J, Stock S, Lüngen M, Gerber A: The nocebo effect: a reason for patients' non-adherence to generic substitution? Pharmazie 2010; 65: 451-6.
25. Miller FG, Colloca L: The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth 2011; 32: 229-43.
26. Lown B: Die verlorene Kunst des Heilens. Stuttgart: Schattauer, 2004
27. Beecher HK: The powerful placebo. J Am Med Assoc 1955; 159: 1602-6.
28. Furmark T, Appel L, Henningsson S, et al.: A link between serotonin-related gene polymorphisms, amygdala activity, and placebo induced relief from social anxiety. J Neurosci 2008; 28: 13066-74.
29. Kaptchuk TJ, Kelley JM, Deykin A, et al.: Do "placebo responders" exist? Contemp Clin Trials 2008; 29: 587-95.
30. Hansen E, Zimmermann M, Dünzl G: Hypnotische Kommunikation mit Notfallpatienten. Notfall Rettungsmed 2010; 13: 314-21.
31. Hansen E: Negativsuggestionen in der Medizin. Z Hypnose Hypnother 2011; 6: 65-82.
32. Stovner LJ, Oftedal G, Straume A, Johnsson A: Nocebo as headache trigger: evidence from a sham-controlled provocation study with RF fields. Acta Neurol Scand 2008; 188 (Suppl): 67-71.
33. Mercado R, Constantoyannis C, Mandat T, Kumar A: Expectation and the placebo effect in Parkinsons disease patients with subthalamic nucleus deep brain stimulation. Movement Disorders 2006; 21: 1457-11461.
34. Rief W, Avorn J, Barsky AJ: Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med 2006; 166: 155-60.
35. Papadopoulos D, Mitsikostas DD: Nocebo effects in multiple sclerosis trials: a meta-analysis. Mult Scler 2010 16 816-28
36. Mitsikostas DD, Mantonakis LI, Chalarakis NG: Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia 2011; 31: 550-61.
37. Liccardi G, Senna G, Russo M, et al.: Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. J Investig Allergol Clin Immunol 2004; 14: 104-7.
38. Lombardi C, Gargioni S, Canonica GW, Passalacqua G: The nocebo effect during oral challenge in subjects with adverse drug reactions. Eur Ann Allergy Clin Immunol 2008; 40: 138-41.
39. de la Cruz M, Hui D, Parsons HA, Bruera E: Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer Cancer 2010 116 766-74
40. Manchikanti L, Pampati VKim Damron K: The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician 2005 8 349-55
41. Mondaini N, Gontero P, Giubilei G, et al.: Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 2007 4 1708-12
42. Silvestri A, Galetta P, Cerquetani E, et al.: Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 2003; 24: 1928-32.
43. Cocco G: Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology 2009; 112: 174-7.
44. Cairns JA, Gent M, Singer J, et al.: Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985; 313: 1369-75.
45. Myers MG, Cairns JA, Singer J: The consent form as a possible cause of side effects. Clin Pharmacol Ther 1987; 42: 250-3.
46. Reeves RR, Ladner ME, Hart RH, Burke RS: Nocebo effects with antidepressant clinical drug trial placebos. Gen Hosp Psychiatry 2007; 29: 275-7.
47. Resolution des Deutschen Schmerztages 2008. Sparmaßnahmen im Gesundheitswesen verletzen Grundrecht auf Leben und körperliche Unversehrtheit. www.schmerz-therapie-deutschland.de/pages/presse/2008/2008-03- 08-PM-12-Resolution.pdf. Last accessed on 18 September 2011
48. Koch M: Petition sausschuss Deutscher Bundestag 9.5. 2011. www.bundestag.de/dokumente/textarchiv/2011/34316512-kw19-pa-petitionen/index. html. Last 18 September 2011
49. Colagiuri B, Zachariae R: Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med 2010 40 3-14
50. Bundesärztekammer: Empfehlungen zur Patientenaufklärung. Dtsch Arztebl 1990; 87(16): 807-8.
51. O'Connor AM, Pennie RA, Dales RE: Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization. J Clin Epidemiol 1996; 49: 1271-6.
52. Dworkin G: The Theory and Practice of Autonomy. Cambridge, UK: Cambridge University Press; 1988
53. Bennett MI, Bagnall AM, Raine G, et al.: Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. Clin J Pain 2011; 27: 623-30.
54. Bosse HM, Schultz JH, Nickel M, et al.: The effect of using standardized patients or peer role play on ratings of undergraduate communication training: A randomized controlled trial. Patient Educ Couns; 2011 (epub ahead of print)
55. Bosse HM, Nickel M, Huwendiek S, Jünger J, Schultz JH, Nikendei C: Peer role-play and standardised patients in communication training: a comparative study on the student perspective on acceptability, realism, and perceived effect. BMC Med Educ 2010; 10: 27.